oxidopamine has been researched along with Craniofacial Pain in 4 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
| Excerpt | Relevance | Reference |
|---|---|---|
| "We confirmed the presence of orofacial pain after unilateral 6-OHDA-injection, which improved after aerobic exercise training." | 1.91 | Exercise Improves Orofacial Pain and Modifies Neuropeptide Expression in a Rat Model of Parkinson's Disease. ( Binda, KH; Chacur, M; Martins, DO, 2023) |
| "CBD therapy is effective for parkinsonism-induced orofacial nociception." | 1.62 | Cannabidiol has therapeutic potential for myofascial pain in female and male parkinsonian rats. ( Del-Bel, E; Dos-Santos-Pereira, M; Guimaraes, FS; Nascimento, GCD; Vivanco-Estela, AN, 2021) |
| "Dopamine is implicated in different orofacial pain-related diseases." | 1.43 | Nigrostriatal dopaminergic depletion produces orofacial static mechanical allodynia. ( Dieb, W; Durif, F; Hafidi, A; Ouachikh, O, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Binda, KH | 1 |
| Chacur, M | 1 |
| Martins, DO | 1 |
| Vivanco-Estela, AN | 1 |
| Dos-Santos-Pereira, M | 1 |
| Guimaraes, FS | 1 |
| Del-Bel, E | 1 |
| Nascimento, GCD | 1 |
| Maegawa, H | 1 |
| Morimoto, Y | 1 |
| Kudo, C | 1 |
| Hanamoto, H | 1 |
| Boku, A | 1 |
| Sugimura, M | 1 |
| Kato, T | 1 |
| Yoshida, A | 1 |
| Niwa, H | 1 |
| Dieb, W | 1 |
| Ouachikh, O | 1 |
| Durif, F | 1 |
| Hafidi, A | 1 |
4 other studies available for oxidopamine and Craniofacial Pain
| Article | Year |
|---|---|
Exercise Improves Orofacial Pain and Modifies Neuropeptide Expression in a Rat Model of Parkinson's Disease.
Topics: Animals; Calcitonin Gene-Related Peptide; Disease Models, Animal; Facial Pain; Neuropeptides; Oxidop | 2023 |
Cannabidiol has therapeutic potential for myofascial pain in female and male parkinsonian rats.
Topics: Analgesics; Animals; Anticonvulsants; Cannabidiol; Estrous Cycle; Facial Pain; Female; Hyperalgesia; | 2021 |
Neural mechanism underlying hyperalgesic response to orofacial pain in Parkinson's disease model rats.
Topics: Animals; Corpus Striatum; Disease Models, Animal; Facial Pain; Formaldehyde; Hyperalgesia; Male; Oxi | 2015 |
Nigrostriatal dopaminergic depletion produces orofacial static mechanical allodynia.
Topics: Animals; Corpus Striatum; Dopamine; Facial Pain; Hyperalgesia; Male; Neuralgia; Oxidopamine; Phospho | 2016 |